Literature DB >> 21140954

[Measuring quality of life in nursing home residents with severe dementia: psychometric properties of the QUALID scale].

D Schalkwijk1, L R Verlare, M T Muller, D L Knol, J T van der Steen.   

Abstract

The Quality of Life in Late Stage Dementia (QUALID) Scale is an instrument to measure quality of life in patients with severe dementia over the last week by means of an interview with a nurse or nurse aid. We interviewed nurse aids on 48 patients with severe dementia in two nursing homes in The Netherlands to determine the psychometric properties of the Dutch translation of the QUALID. Test- retest reliability was good with an Concordance Correlation Coefficient (CCC) of 0.82, (95% Confidence Interval, CI 0.70 - 0.90); interrater reliability was moderate, with an CCC of 0.49 (CI: 0.17-0.72). There was a significant, but low correlation between QUALID ratings and discomfort ratings as observed with the Discomfort Scale-Dementia of Alzheimer Type (DS-DAT), amounting 0.32 (CI: 0.04 - 0.56). The QUALID seems appropriate for measuring quality of life in patients with advanced dementia, when one and the same rater monitors a patient over time in a longitudinal study.

Entities:  

Mesh:

Year:  2009        PMID: 21140954     DOI: 10.1007/bf03079587

Source DB:  PubMed          Journal:  Tijdschr Gerontol Geriatr        ISSN: 0167-9228


  6 in total

1.  Selection bias in family reports on end of life with dementia in nursing homes.

Authors:  Jenny T van der Steen; Luc Deliens; Miel W Ribbe; Bregje D Onwuteaka-Philipsen
Journal:  J Palliat Med       Date:  2012-11-15       Impact factor: 2.947

2.  Psychometric properties of instruments to measure the quality of end-of-life care and dying for long-term care residents with dementia.

Authors:  Mirjam C van Soest-Poortvliet; Jenny T van der Steen; Sheryl Zimmerman; Lauren W Cohen; Maartje S Klapwijk; Mirjam Bezemer; Wilco P Achterberg; Dirk L Knol; Miel W Ribbe; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2011-08-05       Impact factor: 4.147

3.  Symptoms and treatment when death is expected in dementia patients in long-term care facilities.

Authors:  Maartje S Klapwijk; Monique A A Caljouw; Mirjam C van Soest-Poortvliet; Jenny T van der Steen; Wilco P Achterberg
Journal:  BMC Geriatr       Date:  2014-09-02       Impact factor: 3.921

4.  Effects of the Namaste Care Family programme on quality of life of nursing home residents with advanced dementia and on family caregiving experiences: study protocol of a cluster-randomised controlled trial.

Authors:  Hanneke J A Smaling; Karlijn J Joling; Peter M van de Ven; Judith E Bosmans; Joyce Simard; Ladislav Volicer; Wilco P Achterberg; Anneke L Francke; Jenny T van der Steen
Journal:  BMJ Open       Date:  2018-10-15       Impact factor: 2.692

5.  Cost-effectiveness of the Namaste care family program for nursing home residents with advanced dementia in comparison with usual care: a cluster-randomized controlled trial.

Authors:  Mohamed El Alili; Hanneke J A Smaling; Karlijn J Joling; Wilco P Achterberg; Anneke L Francke; Judith E Bosmans; Jenny T van der Steen
Journal:  BMC Health Serv Res       Date:  2020-09-04       Impact factor: 2.655

6.  Improving comfort in people with dementia and pneumonia: a cluster randomized trial.

Authors:  Tessa van der Maaden; Henrica C W de Vet; Wilco P Achterberg; Froukje Boersma; Jos M G A Schols; David R Mehr; Francisca Galindo-Garre; Cees M P M Hertogh; Raymond T C M Koopmans; Jenny T van der Steen
Journal:  BMC Med       Date:  2016-08-11       Impact factor: 8.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.